...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
【24h】

Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.

机译:使用来自健康志愿者的真空管样品在各种取样条件下止血和纤维蛋白溶解活化的分子标记的变化。

获取原文
获取原文并翻译 | 示例

摘要

Molecular makers such as thrombin-antithrombin complex (TAT), prothrombin fragment 1+2 (F1+2), soluble fibrin (SF), and D-dimer, are useful markers in the diagnosis and assessment of various thrombotic conditions. These markers are measured in plasma after blood sampling. Difficult blood sampling is known to falsely elevate plasma TAT levels. However, it is not known exactly why this occurs. In the present study, we examined how levels of molecular markers of haemostatic and fibrinolytic activation change under various sampling conditions using vacuum tube samples from healthy volunteers. When blood was sampled continuously by taking 10 consecutive vacuum tube samples following application of a tourniquet, blood sampling resulted in an accurate assessment of these molecular makers. When blood was sampled continuously by taking vacuum tube samples every one minute over a total of 9 minutes to investigate possible changes in the levels of the molecular markers over time, plasma levels of TAT, SF, and F1+2 gradually increased with time. Plasma levels of TAT, F1+2, and SF increased beyond the normal range over the course of nine minutes. When blood was sampled using three alternative methods, which varied in terms of the duration of needle puncture (sampling B), duration of tourniquet use (sampling C), or both (sampling A), plasma TAT and SF levels were significantly increased with all three methods, compared to control samples. Plasma F1+2 levels were significantly increased with sampling methods A and B, compared to control samples, but not with sampling method C. On the other hand, plasma D-dimer levels were not significantly altered by any of the sampling methods. In conclusion, the results suggest that molecular markers of haemostatic and fibrinolytic activation, except for D-dimer, may be affected by sampling method, particularly the duration of needle puncturing. Therefore, care needs to be taken when using TAT, F1+2, and SF levels to diagnose and estimate activation of the coagulation system.
机译:诸如凝血酶 - 抗凝血酶复合物(TAT),凝血酶原片段1 + 2(F1 + 2),可溶性纤维蛋白(SF)和D-二聚体的分子制片机是在诊断和评估各种血栓形成条件下的有用标记。这些标记在血液取样后在血浆中测量。已知困难的血液取样被错误地提高等离子体TAT水平。但是,它尚不知道这是原因。在本研究中,我们检查了使用来自健康志愿者的真空管样品在各种采样条件下血压和纤维蛋白溶解激活的分子标记水平的分子标记程度。当在施用止血带后通过服用10个连续的真空管样品连续取样血液时,血液取样导致这些分子制造商的准确评估。当通过每分钟一次性的真空管样品连续取样血液,每分钟9分钟,以调查分子标记的水平随时间的时间,血浆水平,SF和F1 + 2随时间逐渐增加。在九分钟的过程中,Tat,F1 + 2和Sf的血浆水平超出正常范围。当使用三种替代方法采样血液时,在针刺持续时间(采样B)的持续时间内变化,止血带使用的持续时间(取样C),或(取样A),血浆TAT和SF水平都显着增加三种方法与对照样品相比。与对照样品相比,采样方法A和B显着增加了血浆F1 + 2水平,但是与采样方法C.另一方面,任何采样方法都没有显着改变等离子体D-二聚体水平。总之,结果表明,除了D-二聚体之外,血压和纤维蛋白溶解激活的分子标记可能受采用采样方法的影响,特别是针刺的持续时间。因此,需要在使用TAT,F1 + 2和SF水平时进行护理,以诊断和估算凝血系统的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号